Track topics on Twitter Track topics that are important to you
26051 Merit Circle Suite 103
United States of America
NewsUnder the agreement, Glaukos and DWTI will conduct joint research for the development of novel intraocular products for the treatment of glaucoma using compounds from DWTI’s proprietary ROCK inh...
Glaukos Corp. and Japanese biotech D. Western Therapeutics Institute Inc. (DWTI) are teaming up to create new glaucoma therapies.
Glaukos Pharmaceutical, an ophthalmic medical technology and pharmaceutical company, and D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company, have announced an agreement.
A study shows Glaukos' iStent inject Trabecular Micro-Bypass System, in combination with cataract surgery, led to a 37% mean -More-
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustai...
Glaukos' iStent inject trabecular micro-bypass system has received approval from the FDA. -More-
Conference Call and Webcast Scheduled for 1:30 p.m. PDT Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the ...
Conference Call and Webcast Scheduled for 1:30 p.m. PST Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the ...
Prospective, multi-center, single-arm clinical trial to evaluate the safety and effectiveness of the Glaukos® Trabecular Micro-Bypass System Model iS3 (three stents per study eye) in subj...
The aim of this study is to evaluate the safety and intraocular pressure (IOP) lowering effect of two iStent inject devices in combination with cataract surgery in patients with mild-to-mo...
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjec...
Glaucoma is the commonest cause of irreversible blindness in the world. Treatment centres around lowering intraocular pressure (IOP) and typically includes medication (least invasive), las...
Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiol...
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...
Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...
Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...
NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...
We have published hundreds of GLAUKOS CORPORATION news stories on BioPortfolio along with dozens of GLAUKOS CORPORATION Clinical Trials and PubMed Articles about GLAUKOS CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLAUKOS CORPORATION Companies in our database. You can also find out about relevant GLAUKOS CORPORATION Drugs and Medications on this site too.
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...